203 related articles for article (PubMed ID: 23257895)
21. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked.
Bowrey DJ; Griffin SM; Wayman J; Karat D; Hayes N; Raimes SA
Surg Endosc; 2006 Nov; 20(11):1725-8. PubMed ID: 17024539
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of symptoms and demographics in diagnosing malignancy or peptic stricture.
Murray IA; Palmer J; Waters C; Dalton HR
World J Gastroenterol; 2012 Aug; 18(32):4357-62. PubMed ID: 22969199
[TBL] [Abstract][Full Text] [Related]
23. The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults.
Liou JM; Lin JT; Wang HP; Huang SP; Lee YC; Shun CT; Lin MT; Wu MS
Gastrointest Endosc; 2005 Jun; 61(7):819-25. PubMed ID: 15933682
[TBL] [Abstract][Full Text] [Related]
24. Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care.
Price SJ; Shephard EA; Stapley SA; Barraclough K; Hamilton WT
Br J Gen Pract; 2014 Sep; 64(626):e584-9. PubMed ID: 25179073
[TBL] [Abstract][Full Text] [Related]
25. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms.
Vakil N; Talley N; van Zanten SV; Flook N; Persson T; Björck E; Lind T; Bolling-Sternevald E;
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):756-61. PubMed ID: 19364542
[TBL] [Abstract][Full Text] [Related]
26. Clinical features of colorectal cancer before diagnosis: a population-based case-control study.
Hamilton W; Round A; Sharp D; Peters TJ
Br J Cancer; 2005 Aug; 93(4):399-405. PubMed ID: 16106247
[TBL] [Abstract][Full Text] [Related]
27. Faecal calprotectin as a marker for oesophago-gastric cancer.
Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM
Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128
[TBL] [Abstract][Full Text] [Related]
28. Even young patients with no alarm symptoms should undergo endoscopy for earlier diagnosis of gastric cancer.
Bołdys H; Marek TA; Wanczura P; Matusik P; Nowak A
Endoscopy; 2003 Jan; 35(1):61-7. PubMed ID: 12510228
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository.
Lieberman D; Fennerty MB; Morris CD; Holub J; Eisen G; Sonnenberg A
Gastroenterology; 2004 Oct; 127(4):1067-75. PubMed ID: 15480985
[TBL] [Abstract][Full Text] [Related]
30. A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.
Tebbutt NC; Norman A; Cunningham D; Iveson T; Seymour M; Hickish T; Harper P; Maisey N; Mochlinski K; Prior Y; Hill M
Ann Oncol; 2002 Oct; 13(10):1568-75. PubMed ID: 12377644
[TBL] [Abstract][Full Text] [Related]
31. Reference values of oesophago-gastric symptoms (EORTC QLQ-OG25) in a population-based setting.
van der Schaaf M; Derogar M; Lagergren P
Eur J Cancer; 2012 Jul; 48(11):1602-7. PubMed ID: 22119353
[TBL] [Abstract][Full Text] [Related]
32. Comparison of oesophageal and gastric cancer in the evaluation of urgent endoscopy referral criteria.
Kumar L; Kholmurodova F; Bull J; Bright T; Watson DI; Shenfine J
ANZ J Surg; 2021 Jul; 91(7-8):1515-1520. PubMed ID: 34124837
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of metastatic cancer in primary care: a case-control study using medical records.
Hamilton W; Barrett J; Stapley S; Sharp D; Rose P
Br J Gen Pract; 2015 Aug; 65(637):e516-22. PubMed ID: 26212847
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of upper gastrointestinal malignancy.
Ryan J; Murkies A
Aust Fam Physician; 2006 Apr; 35(4):200-1. PubMed ID: 16642234
[TBL] [Abstract][Full Text] [Related]
35. Syndrome characteristics of traditional Chinese medicine: summary of a clinical survey in 767 patients with gastric cancer.
Sun DZ; Liu L; Jiao JP; Wei PK; Jiang LD; Xu L
Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):332-40. PubMed ID: 20388473
[TBL] [Abstract][Full Text] [Related]
36. Risk of childhood cancer with symptoms in primary care: a population-based case-control study.
Dommett RM; Redaniel T; Stevens MC; Martin RM; Hamilton W
Br J Gen Pract; 2013 Jan; 63(606):e22-9. PubMed ID: 23336454
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
38. Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Kelleher M; Tebbutt NC; Cunningham D; Andreyev J; Allen M; Hill M; Norman A
Clin Oncol (R Coll Radiol); 2003 May; 15(3):92-7. PubMed ID: 12801044
[TBL] [Abstract][Full Text] [Related]
39. Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2011 Nov; 61(592):e707-14. PubMed ID: 22054334
[TBL] [Abstract][Full Text] [Related]
40. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
